Trademarkia Logo

Canada

C$
Anviglobe
ADVERTISED

on 24 Jan 2025

Last Applicant/ Owned by

CELLTRION, INC.

23, Academy-ro, Yeonsu-guIncheon 22014

KR

Serial Number

2200714 filed on 9th Jun 2022

Registration Number

TMA1286217 registered on 24th Jan 2025

Registration expiry Date

9th Jun 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

Anviglobe

Trademark usage description

pharmaceutical preparations for the treatment of covid-19; pharmaceutical preparations for the treatment of viral diseases, namely, influenza, norovir Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of COVID-19; pharmaceutical preparations for the treatment of viral diseases, namely, influenza, norovirus, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of immune diseases, namely, rheumatoid arthritis, Crohn's disease, colitis, and lupus; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, and inflammatory skin diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of Multiple Sclerosis; pharmaceutical preparations for the treatment of cancer and tumor; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, and anemia; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of Genetic disorders; pharmaceutical preparations for the treatment of neurological disorders, namely Alzheimer's, Huntington's Disease, cerebral palsy and seizure disorders.


Classification kind code

11

Mark Details


Serial Number

2200714

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 1st Dec 2023
Agent Changed
Submitted for opposition 22
on 8th Nov 2023
Search Recorded
Submitted for opposition 20
on 8th Nov 2023
Examiner's First Report
Submitted for opposition 223
on 8th Nov 2023
Total Provisional Refusal
Submitted for opposition 256
on 29th May 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Jul 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th Jul 2022
Created
Submitted for opposition 31
on 27th Jul 2022
Formalized
Submitted for opposition 30
on 9th Jun 2022
Filed
Submitted for opposition 228
on 9th Jun 2022
International Registration